(Q37821616)

21163916

23 August 2017

title

Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939949&resulttype=core&format=json

mild cognitive impairment

13 May 2020

main subject

Alzheimer's disease

0 references

1 reference

inferred from title

cognitive dysfunction

1 reference

Alzheimer's Disease Neuroimaging Initiative

inferred from title

author

5

object named as

Alzheimer's Disease Neuroimaging Initiative

2 references

21163916

23 August 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939949&resulttype=core&format=json

13 May 2020

author name string

Maria Vittoria Spampinato

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939949&resulttype=core&format=json

13 May 2020

Zoran Rumboldt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939949&resulttype=core&format=json

13 May 2020

Robert J Hosker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939949&resulttype=core&format=json

13 May 2020

Jacobo E Mintzer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939949&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

16 December 2010

1 reference

23 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939949&resulttype=core&format=json

13 May 2020

volume

258

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939949&resulttype=core&format=json

13 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939949&resulttype=core&format=json

13 May 2020

page(s)

843-852

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939949&resulttype=core&format=json

Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.

13 May 2020

cites work

1 reference

12 December 2020

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease

1 reference

12 December 2020

Voxel-based morphometry–the methods

1 reference

12 December 2020

Apolipoprotein E, Alzheimer disease, and African Americans

1 reference

12 December 2020

Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes

1 reference

12 December 2020

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

1 reference

12 December 2020

Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

1 reference

12 December 2020

Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.

1 reference

12 December 2020

Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype.

1 reference

12 December 2020

Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele.

1 reference

12 December 2020

Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease.

1 reference

12 December 2020

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

1 reference

12 December 2020

Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology

1 reference

12 December 2020

Mild cognitive impairment: clinical characterization and outcome

1 reference

12 December 2020

Evolution of neuronal changes in the course of Alzheimer's disease.

1 reference

12 December 2020

Intron-3 retention/splicing controls neuronal expression of apolipoprotein E in the CNS.

1 reference

12 December 2020

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

1 reference

12 December 2020

Mild cognitive impairment: transition between aging and Alzheimer's disease.

1 reference

12 December 2020

Usefulness of the Clinical Dementia Rating Scale in Screening for Dementia

1 reference

12 December 2020

Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes.

1 reference

12 December 2020

Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy.

1 reference

12 December 2020

Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease.

1 reference

12 December 2020

A voxel-based morphometric study of ageing in 465 normal adult human brains

1 reference

12 December 2020

Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease

1 reference

12 December 2020

Atrophy rates accelerate in amnestic mild cognitive impairment

1 reference

12 December 2020

Two systems of resting state connectivity between the insula and cingulate cortex

1 reference

12 December 2020

Structural MRI biomarkers for preclinical and mild Alzheimer's disease

1 reference

12 December 2020

Pathology of the insular cortex in Alzheimer disease depends on cortical architecture

1 reference

12 December 2020

The progression of Alzheimer's disease from limbic regions to the neocortex: clinical, radiological and pathological relationships

1 reference

12 December 2020

Apolipoprotein E genotype and gender influence response to tacrine therapy

1 reference

12 December 2020

Specific regional transcription of apolipoprotein E in human brain neurons

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease.

1 reference

12 December 2020

Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease

1 reference

12 December 2020

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers.

1 reference

12 December 2020

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

12 December 2020

Topographic anatomy of the insular region

1 reference

12 December 2020

A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry.

1 reference

12 December 2020

Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention.

1 reference

12 December 2020

Apolipoprotein E ε4 Allele Is Associated with Increased Atrophy in Progressive Mild Cognitive Impairment: A Voxel-Based Morphometric Study

1 reference

12 December 2020

Atrophy of the hippocampus, parietal cortex, and insula in Alzheimer's disease: a volumetric magnetic resonance imaging study.

1 reference

12 December 2020

Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease

1 reference

12 December 2020

Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia

1 reference

12 December 2020

Functional anatomy of the insula: new insights from imaging

1 reference

12 December 2020

Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo

1 reference

12 December 2020

How do you feel? Interoception: the sense of the physiological condition of the body

1 reference

12 December 2020

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.

1 reference

12 December 2020

In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease

1 reference

12 December 2020

Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease

1 reference

12 December 2020

Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice

1 reference

12 December 2020

Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.

1 reference

12 December 2020

Identifiers

DOI

10.1148/RADIOL.10100307

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939949&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6939949&resulttype=core&format=json

13 May 2020

21163916

1 reference